Suppr超能文献

台湾长期照护居民成功应用医保报销抗骨质疏松药物的十种现有骨质疏松症预测工具。

Ten existing osteoporosis prediction tools for the successful application of National Health Insurance-reimbursed anti-osteoporosis medications in long-term care residents in Taiwan.

作者信息

Yang Jiun-Jen, Yen Hung-Kuan, Li Chung-Yi, Chen Hong-Jhe, Liou Horng-Huei, Fu Shau-Huai, Wang Chen-Yu

机构信息

Department of Medical Education, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Taiwan.

Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung, Taiwan.

出版信息

J Formos Med Assoc. 2023 Feb;122(2):139-147. doi: 10.1016/j.jfma.2022.08.009. Epub 2022 Aug 28.

Abstract

BACKGROUND/PURPOSE: Osteoporotic fracture introduce enormous societal and economic burden, especially for long-term care residents (LTCRs). Although osteoporosis prevention for LTCRs is urgently needed, obstacles such as frail status and inconvenient hospital visits hurdled them from necessary examinations and diagnoses. We aimed to test 10 existing osteoporosis screening tools (OSTs), which can be easily used in institutions and serve as a prediction, for accurately determining the outcome of a Taiwan's National Health Insurance (NHI)-reimbursed anti-osteoporosis medications (AOMs) application for LTCRs.

METHODS

This prospective analysis recruited 444 patients from LTC institutions between October 2018 and November 2019. Predictions of whether the NHI-reimbursed AOMs criteria was met were tested for 10 OSTs. The results of OSTs categorized into self-reported or validated based on previous fracture history were self-reported by LTCRs or validated by imaging data and medical records, respectively. The receiver operating characteristic curve and the optimal cut-off points for LTCRs based on Youden's index were explored.

RESULTS

Overall, the validated OSTs had a higher positive predictive value (PPV) and negative predictive value (NPV) summation than the corresponding reported OSTs. The validated FRAX-Major was the best OST (PPV = 63.6%, NPV = 82.4% for the male group and, PPV = 78.8%, NPV = 90.0% for the female group). After applying the optimum cut-off derived from Youden's index, the validated FRAX-Major (PPV = 75.4%, NPV = 92.0%)) remained performed best for men. In female population, validated FRAX-Major (PPV = 87.2%, NPV = 84.1%) and validated osteoporosis prescreening risk assessment (OPERA; PPV = 96.1%, NPV = 79.7%)) both provided good prediction results.

CONCLUSION

FRAX-Major and OPERA have better prediction ability for LTCRs to acquire NHI-reimbursed AOMs. The validated fracture history and adjusted cut-off points could prominently increase the PPV during prediction.

摘要

背景/目的:骨质疏松性骨折带来了巨大的社会和经济负担,尤其是对长期护理机构居民(LTCRs)而言。尽管迫切需要对LTCRs进行骨质疏松症预防,但诸如身体虚弱和就医不便等障碍阻碍了他们接受必要的检查和诊断。我们旨在测试10种现有的骨质疏松症筛查工具(OSTs),这些工具可在机构中轻松使用并用作预测工具,以准确确定台湾地区长期护理机构居民申请国家健康保险(NHI)报销的抗骨质疏松药物(AOMs)的结果。

方法

这项前瞻性分析于2018年10月至2019年11月期间从长期护理机构招募了444名患者。对10种OSTs测试了是否符合NHI报销AOMs标准的预测情况。根据既往骨折史分类为自我报告或经过验证的OSTs结果,分别由LTCRs自我报告或通过影像数据和病历进行验证。探索了基于约登指数的LTCRs的受试者工作特征曲线和最佳临界点。

结果

总体而言,经过验证的OSTs的阳性预测值(PPV)和阴性预测值(NPV)总和高于相应的自我报告的OSTs。经过验证的FRAX-Major是最佳的OST(男性组PPV = 63.6%,NPV = 82.4%;女性组PPV = 78.8%,NPV = 90.0%)。应用从约登指数得出的最佳临界点后,经过验证的FRAX-Major(PPV = 75.4%,NPV = 92.0%)对男性的预测效果仍然最佳。在女性人群中,经过验证的FRAX-Major(PPV = 87.2%,NPV = 84.1%)和经过验证的骨质疏松症预筛查风险评估(OPERA;PPV = 96.1%,NPV = 79.7%)均提供了良好的预测结果。

结论

FRAX-Major和OPERA对LTCRs获得NHI报销的AOMs具有更好的预测能力。经过验证的骨折史和调整后的临界点在预测过程中可显著提高PPV。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验